Dark

Check out our Level2View

LGVN
Longeveron Inc. Common Stock
stock NASDAQ

Market Open

Sep 17, 2026 12:54:22 PM EDT

2.86USD-57.186%(-3.82)1,121,567

2.90Bid 3.38Ask 0.48Spread

Pre-market

Sep 17, 2026 9:29:30 AM EDT

3.11USD-53.443%(-3.57)112,344

After-hours

Sep 15, 2026 4:54:30 PM EDT

6.75USD-1.604%(-0.11)0

OverviewHistoricalExchangesShortsTrends

LGVN Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

LGVN Specific Mentions

As of Sep 17, 2026 12:59:33 PM EDT (<1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

27 days ago • u/Itchy_Temporary_9108 • r/biotech_stocks • what_is_your_favorite_biotech_stocks • C

LGVN and it’s not even close. I’m genuinely way too excited for September lol. Feels like waiting for Friday candy night as a kid.
The main reason is honestly the team. Willard has actual biotech CEO and deal experience, Powell has GSK and Lilly behind him and is literally focused on partnerships, and Hare gives the science real credibility.
If ELPIS II hits, I really think this could change insanely fast. Suddenly it’s not just some tiny biotech at 80 cents. Now you’ve got good trial data, FDA momentum, bigger pharma already talking to them and multiple other programs that become way more interesting.
Obviously if the trial bombs this thing can get absolutely murdered. But if the data are good, man… I think this could get very fun very quickly.
FYI! But it’s my favorite! Not cause it’s safe or “obviously good stock”… but the potential! So don’t bet big!

27 days ago • u/Itchy_Temporary_9108 • r/biotech_stocks • what_is_your_favorite_biotech_stocks • C

LGVN and it’s not even close. I’m genuinely way too excited for September lol. Feels like waiting for Friday candy night as a kid.
The main reason is honestly the team. Willard has actual biotech CEO and deal experience, Powell has GSK and Lilly behind him and is literally focused on partnerships, and Hare gives the science real credibility.
If ELPIS II hits, I really think this could change insanely fast. Suddenly it’s not just some tiny biotech at 80 cents. Now you’ve got good trial data, FDA momentum, bigger pharma already talking to them and multiple other programs that become way more interesting.
Obviously if the trial bombs this thing can get absolutely murdered. But if the data are good, man… I think this could get very fun very quickly.
FYI! But it’s my favorite! Not cause it’s safe or “obviously good stock”… but the potential! So don’t bet big!

Share